Global Meropenem for Injection Supply, Demand and Key Producers, 2026-2032
The global Meropenem for Injection market size is expected to reach $ 2531 million by 2032, rising at a market growth of 4.2% CAGR during the forecast period (2026-2032).
Meropenem for Injection is one of the most widely used broad-spectrum carbapenem antibiotic formulations, primarily indicated for severe pneumonia, sepsis, complicated intra-abdominal infections, central nervous system infections, and other serious hospital-acquired infections caused by resistant Gram-negative pathogens, and it plays a central role in ICUs and critical care departments. Its upstream supply chain mainly includes pharmaceutical-grade beta-lactam core structures and key side-chain intermediates, excipients for sterile injectables such as buffers and stabilizers, water for injection, sterile packaging materials, as well as high-standard aseptic manufacturing lines and testing equipment, all of which require stringent process scale-up, impurity control, and sterility assurance. Downstream customers are primarily general hospitals, tertiary hospitals, regional medical centers, and specialty hospitals, with volume driven through centralized hospital procurement and reimbursement systems. Based on ex-factory pricing, global nominal production capacity of meropenem for injection in 2025 is estimated at approximately 380 million vials, with actual sales volume of around 318 million vials and an average global ex-factory price of about USD 5.8 per vial. Constrained by technical barriers in sterile manufacturing, intensive quality system investments, and persistent pricing pressure from hospital tenders, leading manufacturers typically achieve gross margins in the range of 40%–55%, reflecting a market characterized by stable demand, intense competition, and scalable yet sustainable profitability.
This report studies the global Meropenem for Injection production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Meropenem for Injection and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Meropenem for Injection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Meropenem for Injection total production and demand, 2021-2032, (K Units)
Global Meropenem for Injection total production value, 2021-2032, (USD Million)
Global Meropenem for Injection production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Meropenem for Injection consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Meropenem for Injection domestic production, consumption, key domestic manufacturers and share
Global Meropenem for Injection production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Meropenem for Injection production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Meropenem for Injection production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Meropenem for Injection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sumitomo Pharma, Pfizer, Fresenius, Emcure Pharmaceuticals, Aurobindo Pharma, Sun Pharmaceutical, Hikma Pharmaceuticals, CSPC Pharmaceutical Group, Shenzhen Haibin Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Meropenem for Injection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Meropenem for Injection Market, By Region:
1. How big is the global Meropenem for Injection market?
2. What is the demand of the global Meropenem for Injection market?
3. What is the year over year growth of the global Meropenem for Injection market?
4. What is the production and production value of the global Meropenem for Injection market?
5. Who are the key producers in the global Meropenem for Injection market?
6. What are the growth factors driving the market demand?
Meropenem for Injection is one of the most widely used broad-spectrum carbapenem antibiotic formulations, primarily indicated for severe pneumonia, sepsis, complicated intra-abdominal infections, central nervous system infections, and other serious hospital-acquired infections caused by resistant Gram-negative pathogens, and it plays a central role in ICUs and critical care departments. Its upstream supply chain mainly includes pharmaceutical-grade beta-lactam core structures and key side-chain intermediates, excipients for sterile injectables such as buffers and stabilizers, water for injection, sterile packaging materials, as well as high-standard aseptic manufacturing lines and testing equipment, all of which require stringent process scale-up, impurity control, and sterility assurance. Downstream customers are primarily general hospitals, tertiary hospitals, regional medical centers, and specialty hospitals, with volume driven through centralized hospital procurement and reimbursement systems. Based on ex-factory pricing, global nominal production capacity of meropenem for injection in 2025 is estimated at approximately 380 million vials, with actual sales volume of around 318 million vials and an average global ex-factory price of about USD 5.8 per vial. Constrained by technical barriers in sterile manufacturing, intensive quality system investments, and persistent pricing pressure from hospital tenders, leading manufacturers typically achieve gross margins in the range of 40%–55%, reflecting a market characterized by stable demand, intense competition, and scalable yet sustainable profitability.
This report studies the global Meropenem for Injection production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Meropenem for Injection and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Meropenem for Injection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Meropenem for Injection total production and demand, 2021-2032, (K Units)
Global Meropenem for Injection total production value, 2021-2032, (USD Million)
Global Meropenem for Injection production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Meropenem for Injection consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Meropenem for Injection domestic production, consumption, key domestic manufacturers and share
Global Meropenem for Injection production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Meropenem for Injection production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Meropenem for Injection production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Meropenem for Injection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sumitomo Pharma, Pfizer, Fresenius, Emcure Pharmaceuticals, Aurobindo Pharma, Sun Pharmaceutical, Hikma Pharmaceuticals, CSPC Pharmaceutical Group, Shenzhen Haibin Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Meropenem for Injection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Meropenem for Injection Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 0.25 g (Calculated as C??H??N?O?S)
- 0.5 g (Calculated as C??H??N?O?S)
- 1.0 g (Calculated as C??H??N?O?S)
- Severe Hospital-acquired Infections
- Drug-resistant Gram-negative Infections
- Others
- Hospital
- Clinic
- Others
- Sumitomo Pharma
- Pfizer
- Fresenius
- Emcure Pharmaceuticals
- Aurobindo Pharma
- Sun Pharmaceutical
- Hikma Pharmaceuticals
- CSPC Pharmaceutical Group
- Shenzhen Haibin Pharmaceutical
1. How big is the global Meropenem for Injection market?
2. What is the demand of the global Meropenem for Injection market?
3. What is the year over year growth of the global Meropenem for Injection market?
4. What is the production and production value of the global Meropenem for Injection market?
5. Who are the key producers in the global Meropenem for Injection market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Meropenem for Injection Introduction
1.2 World Meropenem for Injection Supply & Forecast
1.2.1 World Meropenem for Injection Production Value (2021 & 2025 & 2032)
1.2.2 World Meropenem for Injection Production (2021-2032)
1.2.3 World Meropenem for Injection Pricing Trends (2021-2032)
1.3 World Meropenem for Injection Production by Region (Based on Production Site)
1.3.1 World Meropenem for Injection Production Value by Region (2021-2032)
1.3.2 World Meropenem for Injection Production by Region (2021-2032)
1.3.3 World Meropenem for Injection Average Price by Region (2021-2032)
1.3.4 North America Meropenem for Injection Production (2021-2032)
1.3.5 Europe Meropenem for Injection Production (2021-2032)
1.3.6 China Meropenem for Injection Production (2021-2032)
1.3.7 Japan Meropenem for Injection Production (2021-2032)
1.3.8 India Meropenem for Injection Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Meropenem for Injection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Meropenem for Injection Major Market Trends
2 DEMAND SUMMARY
2.1 World Meropenem for Injection Demand (2021-2032)
2.2 World Meropenem for Injection Consumption by Region
2.2.1 World Meropenem for Injection Consumption by Region (2021-2026)
2.2.2 World Meropenem for Injection Consumption Forecast by Region (2027-2032)
2.3 United States Meropenem for Injection Consumption (2021-2032)
2.4 China Meropenem for Injection Consumption (2021-2032)
2.5 Europe Meropenem for Injection Consumption (2021-2032)
2.6 Japan Meropenem for Injection Consumption (2021-2032)
2.7 South Korea Meropenem for Injection Consumption (2021-2032)
2.8 ASEAN Meropenem for Injection Consumption (2021-2032)
2.9 India Meropenem for Injection Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Meropenem for Injection Production Value by Manufacturer (2021-2026)
3.2 World Meropenem for Injection Production by Manufacturer (2021-2026)
3.3 World Meropenem for Injection Average Price by Manufacturer (2021-2026)
3.4 Meropenem for Injection Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Meropenem for Injection Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Meropenem for Injection in 2025
3.5.3 Global Concentration Ratios (CR8) for Meropenem for Injection in 2025
3.6 Meropenem for Injection Market: Overall Company Footprint Analysis
3.6.1 Meropenem for Injection Market: Region Footprint
3.6.2 Meropenem for Injection Market: Company Product Type Footprint
3.6.3 Meropenem for Injection Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Meropenem for Injection Production Value Comparison
4.1.1 United States VS China: Meropenem for Injection Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Meropenem for Injection Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Meropenem for Injection Production Comparison
4.2.1 United States VS China: Meropenem for Injection Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Meropenem for Injection Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Meropenem for Injection Consumption Comparison
4.3.1 United States VS China: Meropenem for Injection Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Meropenem for Injection Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Meropenem for Injection Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Meropenem for Injection Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Meropenem for Injection Production Value (2021-2026)
4.4.3 United States Based Manufacturers Meropenem for Injection Production (2021-2026)
4.5 China Based Meropenem for Injection Manufacturers and Market Share
4.5.1 China Based Meropenem for Injection Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Meropenem for Injection Production Value (2021-2026)
4.5.3 China Based Manufacturers Meropenem for Injection Production (2021-2026)
4.6 Rest of World Based Meropenem for Injection Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Meropenem for Injection Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Meropenem for Injection Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Meropenem for Injection Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Meropenem for Injection Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 0.25 g (Calculated as C??H??N?O?S)
5.2.2 0.5 g (Calculated as C??H??N?O?S)
5.2.3 1.0 g (Calculated as C??H??N?O?S)
5.3 Market Segment by Type
5.3.1 World Meropenem for Injection Production by Type (2021-2032)
5.3.2 World Meropenem for Injection Production Value by Type (2021-2032)
5.3.3 World Meropenem for Injection Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY CLINICAL INDICATION
6.1 World Meropenem for Injection Market Size Overview by Clinical Indication: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Clinical Indication
6.2.1 Severe Hospital-acquired Infections
6.2.2 Drug-resistant Gram-negative Infections
6.2.3 Others
6.3 Market Segment by Clinical Indication
6.3.1 World Meropenem for Injection Production by Clinical Indication (2021-2032)
6.3.2 World Meropenem for Injection Production Value by Clinical Indication (2021-2032)
6.3.3 World Meropenem for Injection Average Price by Clinical Indication (2021-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Meropenem for Injection Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Hospital
7.2.2 Clinic
7.2.3 Others
7.3 Market Segment by Application
7.3.1 World Meropenem for Injection Production by Application (2021-2032)
7.3.2 World Meropenem for Injection Production Value by Application (2021-2032)
7.3.3 World Meropenem for Injection Average Price by Application (2021-2032)
8 COMPANY PROFILES
8.1 Sumitomo Pharma
8.1.1 Sumitomo Pharma Details
8.1.2 Sumitomo Pharma Major Business
8.1.3 Sumitomo Pharma Meropenem for Injection Product and Services
8.1.4 Sumitomo Pharma Meropenem for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.1.5 Sumitomo Pharma Recent Developments/Updates
8.1.6 Sumitomo Pharma Competitive Strengths & Weaknesses
8.2 Pfizer
8.2.1 Pfizer Details
8.2.2 Pfizer Major Business
8.2.3 Pfizer Meropenem for Injection Product and Services
8.2.4 Pfizer Meropenem for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.2.5 Pfizer Recent Developments/Updates
8.2.6 Pfizer Competitive Strengths & Weaknesses
8.3 Fresenius
8.3.1 Fresenius Details
8.3.2 Fresenius Major Business
8.3.3 Fresenius Meropenem for Injection Product and Services
8.3.4 Fresenius Meropenem for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.3.5 Fresenius Recent Developments/Updates
8.3.6 Fresenius Competitive Strengths & Weaknesses
8.4 Emcure Pharmaceuticals
8.4.1 Emcure Pharmaceuticals Details
8.4.2 Emcure Pharmaceuticals Major Business
8.4.3 Emcure Pharmaceuticals Meropenem for Injection Product and Services
8.4.4 Emcure Pharmaceuticals Meropenem for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.4.5 Emcure Pharmaceuticals Recent Developments/Updates
8.4.6 Emcure Pharmaceuticals Competitive Strengths & Weaknesses
8.5 Aurobindo Pharma
8.5.1 Aurobindo Pharma Details
8.5.2 Aurobindo Pharma Major Business
8.5.3 Aurobindo Pharma Meropenem for Injection Product and Services
8.5.4 Aurobindo Pharma Meropenem for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.5.5 Aurobindo Pharma Recent Developments/Updates
8.5.6 Aurobindo Pharma Competitive Strengths & Weaknesses
8.6 Sun Pharmaceutical
8.6.1 Sun Pharmaceutical Details
8.6.2 Sun Pharmaceutical Major Business
8.6.3 Sun Pharmaceutical Meropenem for Injection Product and Services
8.6.4 Sun Pharmaceutical Meropenem for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.6.5 Sun Pharmaceutical Recent Developments/Updates
8.6.6 Sun Pharmaceutical Competitive Strengths & Weaknesses
8.7 Hikma Pharmaceuticals
8.7.1 Hikma Pharmaceuticals Details
8.7.2 Hikma Pharmaceuticals Major Business
8.7.3 Hikma Pharmaceuticals Meropenem for Injection Product and Services
8.7.4 Hikma Pharmaceuticals Meropenem for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.7.5 Hikma Pharmaceuticals Recent Developments/Updates
8.7.6 Hikma Pharmaceuticals Competitive Strengths & Weaknesses
8.8 CSPC Pharmaceutical Group
8.8.1 CSPC Pharmaceutical Group Details
8.8.2 CSPC Pharmaceutical Group Major Business
8.8.3 CSPC Pharmaceutical Group Meropenem for Injection Product and Services
8.8.4 CSPC Pharmaceutical Group Meropenem for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.8.5 CSPC Pharmaceutical Group Recent Developments/Updates
8.8.6 CSPC Pharmaceutical Group Competitive Strengths & Weaknesses
8.9 Shenzhen Haibin Pharmaceutical
8.9.1 Shenzhen Haibin Pharmaceutical Details
8.9.2 Shenzhen Haibin Pharmaceutical Major Business
8.9.3 Shenzhen Haibin Pharmaceutical Meropenem for Injection Product and Services
8.9.4 Shenzhen Haibin Pharmaceutical Meropenem for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.9.5 Shenzhen Haibin Pharmaceutical Recent Developments/Updates
8.9.6 Shenzhen Haibin Pharmaceutical Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Meropenem for Injection Industry Chain
9.2 Meropenem for Injection Upstream Analysis
9.2.1 Meropenem for Injection Core Raw Materials
9.2.2 Main Manufacturers of Meropenem for Injection Core Raw Materials
9.3 Midstream Analysis
9.4 Downstream Analysis
9.5 Meropenem for Injection Production Mode
9.6 Meropenem for Injection Procurement Model
9.7 Meropenem for Injection Industry Sales Model and Sales Channels
9.7.1 Meropenem for Injection Sales Model
9.7.2 Meropenem for Injection Typical Distributors
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Meropenem for Injection Introduction
1.2 World Meropenem for Injection Supply & Forecast
1.2.1 World Meropenem for Injection Production Value (2021 & 2025 & 2032)
1.2.2 World Meropenem for Injection Production (2021-2032)
1.2.3 World Meropenem for Injection Pricing Trends (2021-2032)
1.3 World Meropenem for Injection Production by Region (Based on Production Site)
1.3.1 World Meropenem for Injection Production Value by Region (2021-2032)
1.3.2 World Meropenem for Injection Production by Region (2021-2032)
1.3.3 World Meropenem for Injection Average Price by Region (2021-2032)
1.3.4 North America Meropenem for Injection Production (2021-2032)
1.3.5 Europe Meropenem for Injection Production (2021-2032)
1.3.6 China Meropenem for Injection Production (2021-2032)
1.3.7 Japan Meropenem for Injection Production (2021-2032)
1.3.8 India Meropenem for Injection Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Meropenem for Injection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Meropenem for Injection Major Market Trends
2 DEMAND SUMMARY
2.1 World Meropenem for Injection Demand (2021-2032)
2.2 World Meropenem for Injection Consumption by Region
2.2.1 World Meropenem for Injection Consumption by Region (2021-2026)
2.2.2 World Meropenem for Injection Consumption Forecast by Region (2027-2032)
2.3 United States Meropenem for Injection Consumption (2021-2032)
2.4 China Meropenem for Injection Consumption (2021-2032)
2.5 Europe Meropenem for Injection Consumption (2021-2032)
2.6 Japan Meropenem for Injection Consumption (2021-2032)
2.7 South Korea Meropenem for Injection Consumption (2021-2032)
2.8 ASEAN Meropenem for Injection Consumption (2021-2032)
2.9 India Meropenem for Injection Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Meropenem for Injection Production Value by Manufacturer (2021-2026)
3.2 World Meropenem for Injection Production by Manufacturer (2021-2026)
3.3 World Meropenem for Injection Average Price by Manufacturer (2021-2026)
3.4 Meropenem for Injection Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Meropenem for Injection Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Meropenem for Injection in 2025
3.5.3 Global Concentration Ratios (CR8) for Meropenem for Injection in 2025
3.6 Meropenem for Injection Market: Overall Company Footprint Analysis
3.6.1 Meropenem for Injection Market: Region Footprint
3.6.2 Meropenem for Injection Market: Company Product Type Footprint
3.6.3 Meropenem for Injection Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Meropenem for Injection Production Value Comparison
4.1.1 United States VS China: Meropenem for Injection Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Meropenem for Injection Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Meropenem for Injection Production Comparison
4.2.1 United States VS China: Meropenem for Injection Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Meropenem for Injection Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Meropenem for Injection Consumption Comparison
4.3.1 United States VS China: Meropenem for Injection Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Meropenem for Injection Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Meropenem for Injection Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Meropenem for Injection Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Meropenem for Injection Production Value (2021-2026)
4.4.3 United States Based Manufacturers Meropenem for Injection Production (2021-2026)
4.5 China Based Meropenem for Injection Manufacturers and Market Share
4.5.1 China Based Meropenem for Injection Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Meropenem for Injection Production Value (2021-2026)
4.5.3 China Based Manufacturers Meropenem for Injection Production (2021-2026)
4.6 Rest of World Based Meropenem for Injection Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Meropenem for Injection Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Meropenem for Injection Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Meropenem for Injection Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Meropenem for Injection Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 0.25 g (Calculated as C??H??N?O?S)
5.2.2 0.5 g (Calculated as C??H??N?O?S)
5.2.3 1.0 g (Calculated as C??H??N?O?S)
5.3 Market Segment by Type
5.3.1 World Meropenem for Injection Production by Type (2021-2032)
5.3.2 World Meropenem for Injection Production Value by Type (2021-2032)
5.3.3 World Meropenem for Injection Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY CLINICAL INDICATION
6.1 World Meropenem for Injection Market Size Overview by Clinical Indication: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Clinical Indication
6.2.1 Severe Hospital-acquired Infections
6.2.2 Drug-resistant Gram-negative Infections
6.2.3 Others
6.3 Market Segment by Clinical Indication
6.3.1 World Meropenem for Injection Production by Clinical Indication (2021-2032)
6.3.2 World Meropenem for Injection Production Value by Clinical Indication (2021-2032)
6.3.3 World Meropenem for Injection Average Price by Clinical Indication (2021-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Meropenem for Injection Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Hospital
7.2.2 Clinic
7.2.3 Others
7.3 Market Segment by Application
7.3.1 World Meropenem for Injection Production by Application (2021-2032)
7.3.2 World Meropenem for Injection Production Value by Application (2021-2032)
7.3.3 World Meropenem for Injection Average Price by Application (2021-2032)
8 COMPANY PROFILES
8.1 Sumitomo Pharma
8.1.1 Sumitomo Pharma Details
8.1.2 Sumitomo Pharma Major Business
8.1.3 Sumitomo Pharma Meropenem for Injection Product and Services
8.1.4 Sumitomo Pharma Meropenem for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.1.5 Sumitomo Pharma Recent Developments/Updates
8.1.6 Sumitomo Pharma Competitive Strengths & Weaknesses
8.2 Pfizer
8.2.1 Pfizer Details
8.2.2 Pfizer Major Business
8.2.3 Pfizer Meropenem for Injection Product and Services
8.2.4 Pfizer Meropenem for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.2.5 Pfizer Recent Developments/Updates
8.2.6 Pfizer Competitive Strengths & Weaknesses
8.3 Fresenius
8.3.1 Fresenius Details
8.3.2 Fresenius Major Business
8.3.3 Fresenius Meropenem for Injection Product and Services
8.3.4 Fresenius Meropenem for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.3.5 Fresenius Recent Developments/Updates
8.3.6 Fresenius Competitive Strengths & Weaknesses
8.4 Emcure Pharmaceuticals
8.4.1 Emcure Pharmaceuticals Details
8.4.2 Emcure Pharmaceuticals Major Business
8.4.3 Emcure Pharmaceuticals Meropenem for Injection Product and Services
8.4.4 Emcure Pharmaceuticals Meropenem for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.4.5 Emcure Pharmaceuticals Recent Developments/Updates
8.4.6 Emcure Pharmaceuticals Competitive Strengths & Weaknesses
8.5 Aurobindo Pharma
8.5.1 Aurobindo Pharma Details
8.5.2 Aurobindo Pharma Major Business
8.5.3 Aurobindo Pharma Meropenem for Injection Product and Services
8.5.4 Aurobindo Pharma Meropenem for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.5.5 Aurobindo Pharma Recent Developments/Updates
8.5.6 Aurobindo Pharma Competitive Strengths & Weaknesses
8.6 Sun Pharmaceutical
8.6.1 Sun Pharmaceutical Details
8.6.2 Sun Pharmaceutical Major Business
8.6.3 Sun Pharmaceutical Meropenem for Injection Product and Services
8.6.4 Sun Pharmaceutical Meropenem for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.6.5 Sun Pharmaceutical Recent Developments/Updates
8.6.6 Sun Pharmaceutical Competitive Strengths & Weaknesses
8.7 Hikma Pharmaceuticals
8.7.1 Hikma Pharmaceuticals Details
8.7.2 Hikma Pharmaceuticals Major Business
8.7.3 Hikma Pharmaceuticals Meropenem for Injection Product and Services
8.7.4 Hikma Pharmaceuticals Meropenem for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.7.5 Hikma Pharmaceuticals Recent Developments/Updates
8.7.6 Hikma Pharmaceuticals Competitive Strengths & Weaknesses
8.8 CSPC Pharmaceutical Group
8.8.1 CSPC Pharmaceutical Group Details
8.8.2 CSPC Pharmaceutical Group Major Business
8.8.3 CSPC Pharmaceutical Group Meropenem for Injection Product and Services
8.8.4 CSPC Pharmaceutical Group Meropenem for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.8.5 CSPC Pharmaceutical Group Recent Developments/Updates
8.8.6 CSPC Pharmaceutical Group Competitive Strengths & Weaknesses
8.9 Shenzhen Haibin Pharmaceutical
8.9.1 Shenzhen Haibin Pharmaceutical Details
8.9.2 Shenzhen Haibin Pharmaceutical Major Business
8.9.3 Shenzhen Haibin Pharmaceutical Meropenem for Injection Product and Services
8.9.4 Shenzhen Haibin Pharmaceutical Meropenem for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.9.5 Shenzhen Haibin Pharmaceutical Recent Developments/Updates
8.9.6 Shenzhen Haibin Pharmaceutical Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Meropenem for Injection Industry Chain
9.2 Meropenem for Injection Upstream Analysis
9.2.1 Meropenem for Injection Core Raw Materials
9.2.2 Main Manufacturers of Meropenem for Injection Core Raw Materials
9.3 Midstream Analysis
9.4 Downstream Analysis
9.5 Meropenem for Injection Production Mode
9.6 Meropenem for Injection Procurement Model
9.7 Meropenem for Injection Industry Sales Model and Sales Channels
9.7.1 Meropenem for Injection Sales Model
9.7.2 Meropenem for Injection Typical Distributors
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Meropenem for Injection Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Meropenem for Injection Production Value by Region (2021-2026) & (USD Million)
Table 3. World Meropenem for Injection Production Value by Region (2027-2032) & (USD Million)
Table 4. World Meropenem for Injection Production Value Market Share by Region (2021-2026)
Table 5. World Meropenem for Injection Production Value Market Share by Region (2027-2032)
Table 6. World Meropenem for Injection Production by Region (2021-2026) & (K Units)
Table 7. World Meropenem for Injection Production by Region (2027-2032) & (K Units)
Table 8. World Meropenem for Injection Production Market Share by Region (2021-2026)
Table 9. World Meropenem for Injection Production Market Share by Region (2027-2032)
Table 10. World Meropenem for Injection Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Meropenem for Injection Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Meropenem for Injection Major Market Trends
Table 13. World Meropenem for Injection Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Meropenem for Injection Consumption by Region (2021-2026) & (K Units)
Table 15. World Meropenem for Injection Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Meropenem for Injection Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Meropenem for Injection Producers in 2025
Table 18. World Meropenem for Injection Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Meropenem for Injection Producers in 2025
Table 20. World Meropenem for Injection Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Meropenem for Injection Company Evaluation Quadrant
Table 22. World Meropenem for Injection Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Meropenem for Injection Production Site of Key Manufacturer
Table 24. Meropenem for Injection Market: Company Product Type Footprint
Table 25. Meropenem for Injection Market: Company Product Application Footprint
Table 26. Meropenem for Injection Competitive Factors
Table 27. Meropenem for Injection New Entrant and Capacity Expansion Plans
Table 28. Meropenem for Injection Mergers & Acquisitions Activity
Table 29. United States VS China Meropenem for Injection Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Meropenem for Injection Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Meropenem for Injection Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Meropenem for Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Meropenem for Injection Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Meropenem for Injection Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Meropenem for Injection Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Meropenem for Injection Production Market Share (2021-2026)
Table 37. China Based Meropenem for Injection Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Meropenem for Injection Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Meropenem for Injection Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Meropenem for Injection Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Meropenem for Injection Production Market Share (2021-2026)
Table 42. Rest of World Based Meropenem for Injection Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Meropenem for Injection Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Meropenem for Injection Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Meropenem for Injection Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Meropenem for Injection Production Market Share (2021-2026)
Table 47. World Meropenem for Injection Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Meropenem for Injection Production by Type (2021-2026) & (K Units)
Table 49. World Meropenem for Injection Production by Type (2027-2032) & (K Units)
Table 50. World Meropenem for Injection Production Value by Type (2021-2026) & (USD Million)
Table 51. World Meropenem for Injection Production Value by Type (2027-2032) & (USD Million)
Table 52. World Meropenem for Injection Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Meropenem for Injection Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Meropenem for Injection Production Value by Clinical Indication, (USD Million), 2021 & 2025 & 2032
Table 55. World Meropenem for Injection Production by Clinical Indication (2021-2026) & (K Units)
Table 56. World Meropenem for Injection Production by Clinical Indication (2027-2032) & (K Units)
Table 57. World Meropenem for Injection Production Value by Clinical Indication (2021-2026) & (USD Million)
Table 58. World Meropenem for Injection Production Value by Clinical Indication (2027-2032) & (USD Million)
Table 59. World Meropenem for Injection Average Price by Clinical Indication (2021-2026) & (US$/Unit)
Table 60. World Meropenem for Injection Average Price by Clinical Indication (2027-2032) & (US$/Unit)
Table 61. World Meropenem for Injection Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 62. World Meropenem for Injection Production by Application (2021-2026) & (K Units)
Table 63. World Meropenem for Injection Production by Application (2027-2032) & (K Units)
Table 64. World Meropenem for Injection Production Value by Application (2021-2026) & (USD Million)
Table 65. World Meropenem for Injection Production Value by Application (2027-2032) & (USD Million)
Table 66. World Meropenem for Injection Average Price by Application (2021-2026) & (US$/Unit)
Table 67. World Meropenem for Injection Average Price by Application (2027-2032) & (US$/Unit)
Table 68. Sumitomo Pharma Basic Information, Manufacturing Base and Competitors
Table 69. Sumitomo Pharma Major Business
Table 70. Sumitomo Pharma Meropenem for Injection Product and Services
Table 71. Sumitomo Pharma Meropenem for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Sumitomo Pharma Recent Developments/Updates
Table 73. Sumitomo Pharma Competitive Strengths & Weaknesses
Table 74. Pfizer Basic Information, Manufacturing Base and Competitors
Table 75. Pfizer Major Business
Table 76. Pfizer Meropenem for Injection Product and Services
Table 77. Pfizer Meropenem for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Pfizer Recent Developments/Updates
Table 79. Pfizer Competitive Strengths & Weaknesses
Table 80. Fresenius Basic Information, Manufacturing Base and Competitors
Table 81. Fresenius Major Business
Table 82. Fresenius Meropenem for Injection Product and Services
Table 83. Fresenius Meropenem for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Fresenius Recent Developments/Updates
Table 85. Fresenius Competitive Strengths & Weaknesses
Table 86. Emcure Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 87. Emcure Pharmaceuticals Major Business
Table 88. Emcure Pharmaceuticals Meropenem for Injection Product and Services
Table 89. Emcure Pharmaceuticals Meropenem for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Emcure Pharmaceuticals Recent Developments/Updates
Table 91. Emcure Pharmaceuticals Competitive Strengths & Weaknesses
Table 92. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 93. Aurobindo Pharma Major Business
Table 94. Aurobindo Pharma Meropenem for Injection Product and Services
Table 95. Aurobindo Pharma Meropenem for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 96. Aurobindo Pharma Recent Developments/Updates
Table 97. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 98. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 99. Sun Pharmaceutical Major Business
Table 100. Sun Pharmaceutical Meropenem for Injection Product and Services
Table 101. Sun Pharmaceutical Meropenem for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 102. Sun Pharmaceutical Recent Developments/Updates
Table 103. Sun Pharmaceutical Competitive Strengths & Weaknesses
Table 104. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 105. Hikma Pharmaceuticals Major Business
Table 106. Hikma Pharmaceuticals Meropenem for Injection Product and Services
Table 107. Hikma Pharmaceuticals Meropenem for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 108. Hikma Pharmaceuticals Recent Developments/Updates
Table 109. Hikma Pharmaceuticals Competitive Strengths & Weaknesses
Table 110. CSPC Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 111. CSPC Pharmaceutical Group Major Business
Table 112. CSPC Pharmaceutical Group Meropenem for Injection Product and Services
Table 113. CSPC Pharmaceutical Group Meropenem for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. CSPC Pharmaceutical Group Recent Developments/Updates
Table 115. CSPC Pharmaceutical Group Competitive Strengths & Weaknesses
Table 116. Shenzhen Haibin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 117. Shenzhen Haibin Pharmaceutical Major Business
Table 118. Shenzhen Haibin Pharmaceutical Meropenem for Injection Product and Services
Table 119. Shenzhen Haibin Pharmaceutical Meropenem for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. Shenzhen Haibin Pharmaceutical Recent Developments/Updates
Table 121. Shenzhen Haibin Pharmaceutical Competitive Strengths & Weaknesses
Table 122. Global Key Players of Meropenem for Injection Upstream (Raw Materials)
Table 123. Global Meropenem for Injection Typical Customers
Table 124. Meropenem for Injection Typical Distributors
Table 1. World Meropenem for Injection Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Meropenem for Injection Production Value by Region (2021-2026) & (USD Million)
Table 3. World Meropenem for Injection Production Value by Region (2027-2032) & (USD Million)
Table 4. World Meropenem for Injection Production Value Market Share by Region (2021-2026)
Table 5. World Meropenem for Injection Production Value Market Share by Region (2027-2032)
Table 6. World Meropenem for Injection Production by Region (2021-2026) & (K Units)
Table 7. World Meropenem for Injection Production by Region (2027-2032) & (K Units)
Table 8. World Meropenem for Injection Production Market Share by Region (2021-2026)
Table 9. World Meropenem for Injection Production Market Share by Region (2027-2032)
Table 10. World Meropenem for Injection Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Meropenem for Injection Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Meropenem for Injection Major Market Trends
Table 13. World Meropenem for Injection Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Meropenem for Injection Consumption by Region (2021-2026) & (K Units)
Table 15. World Meropenem for Injection Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Meropenem for Injection Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Meropenem for Injection Producers in 2025
Table 18. World Meropenem for Injection Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Meropenem for Injection Producers in 2025
Table 20. World Meropenem for Injection Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Meropenem for Injection Company Evaluation Quadrant
Table 22. World Meropenem for Injection Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Meropenem for Injection Production Site of Key Manufacturer
Table 24. Meropenem for Injection Market: Company Product Type Footprint
Table 25. Meropenem for Injection Market: Company Product Application Footprint
Table 26. Meropenem for Injection Competitive Factors
Table 27. Meropenem for Injection New Entrant and Capacity Expansion Plans
Table 28. Meropenem for Injection Mergers & Acquisitions Activity
Table 29. United States VS China Meropenem for Injection Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Meropenem for Injection Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Meropenem for Injection Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Meropenem for Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Meropenem for Injection Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Meropenem for Injection Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Meropenem for Injection Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Meropenem for Injection Production Market Share (2021-2026)
Table 37. China Based Meropenem for Injection Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Meropenem for Injection Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Meropenem for Injection Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Meropenem for Injection Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Meropenem for Injection Production Market Share (2021-2026)
Table 42. Rest of World Based Meropenem for Injection Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Meropenem for Injection Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Meropenem for Injection Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Meropenem for Injection Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Meropenem for Injection Production Market Share (2021-2026)
Table 47. World Meropenem for Injection Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Meropenem for Injection Production by Type (2021-2026) & (K Units)
Table 49. World Meropenem for Injection Production by Type (2027-2032) & (K Units)
Table 50. World Meropenem for Injection Production Value by Type (2021-2026) & (USD Million)
Table 51. World Meropenem for Injection Production Value by Type (2027-2032) & (USD Million)
Table 52. World Meropenem for Injection Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Meropenem for Injection Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Meropenem for Injection Production Value by Clinical Indication, (USD Million), 2021 & 2025 & 2032
Table 55. World Meropenem for Injection Production by Clinical Indication (2021-2026) & (K Units)
Table 56. World Meropenem for Injection Production by Clinical Indication (2027-2032) & (K Units)
Table 57. World Meropenem for Injection Production Value by Clinical Indication (2021-2026) & (USD Million)
Table 58. World Meropenem for Injection Production Value by Clinical Indication (2027-2032) & (USD Million)
Table 59. World Meropenem for Injection Average Price by Clinical Indication (2021-2026) & (US$/Unit)
Table 60. World Meropenem for Injection Average Price by Clinical Indication (2027-2032) & (US$/Unit)
Table 61. World Meropenem for Injection Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 62. World Meropenem for Injection Production by Application (2021-2026) & (K Units)
Table 63. World Meropenem for Injection Production by Application (2027-2032) & (K Units)
Table 64. World Meropenem for Injection Production Value by Application (2021-2026) & (USD Million)
Table 65. World Meropenem for Injection Production Value by Application (2027-2032) & (USD Million)
Table 66. World Meropenem for Injection Average Price by Application (2021-2026) & (US$/Unit)
Table 67. World Meropenem for Injection Average Price by Application (2027-2032) & (US$/Unit)
Table 68. Sumitomo Pharma Basic Information, Manufacturing Base and Competitors
Table 69. Sumitomo Pharma Major Business
Table 70. Sumitomo Pharma Meropenem for Injection Product and Services
Table 71. Sumitomo Pharma Meropenem for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Sumitomo Pharma Recent Developments/Updates
Table 73. Sumitomo Pharma Competitive Strengths & Weaknesses
Table 74. Pfizer Basic Information, Manufacturing Base and Competitors
Table 75. Pfizer Major Business
Table 76. Pfizer Meropenem for Injection Product and Services
Table 77. Pfizer Meropenem for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Pfizer Recent Developments/Updates
Table 79. Pfizer Competitive Strengths & Weaknesses
Table 80. Fresenius Basic Information, Manufacturing Base and Competitors
Table 81. Fresenius Major Business
Table 82. Fresenius Meropenem for Injection Product and Services
Table 83. Fresenius Meropenem for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Fresenius Recent Developments/Updates
Table 85. Fresenius Competitive Strengths & Weaknesses
Table 86. Emcure Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 87. Emcure Pharmaceuticals Major Business
Table 88. Emcure Pharmaceuticals Meropenem for Injection Product and Services
Table 89. Emcure Pharmaceuticals Meropenem for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Emcure Pharmaceuticals Recent Developments/Updates
Table 91. Emcure Pharmaceuticals Competitive Strengths & Weaknesses
Table 92. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 93. Aurobindo Pharma Major Business
Table 94. Aurobindo Pharma Meropenem for Injection Product and Services
Table 95. Aurobindo Pharma Meropenem for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 96. Aurobindo Pharma Recent Developments/Updates
Table 97. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 98. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 99. Sun Pharmaceutical Major Business
Table 100. Sun Pharmaceutical Meropenem for Injection Product and Services
Table 101. Sun Pharmaceutical Meropenem for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 102. Sun Pharmaceutical Recent Developments/Updates
Table 103. Sun Pharmaceutical Competitive Strengths & Weaknesses
Table 104. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 105. Hikma Pharmaceuticals Major Business
Table 106. Hikma Pharmaceuticals Meropenem for Injection Product and Services
Table 107. Hikma Pharmaceuticals Meropenem for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 108. Hikma Pharmaceuticals Recent Developments/Updates
Table 109. Hikma Pharmaceuticals Competitive Strengths & Weaknesses
Table 110. CSPC Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 111. CSPC Pharmaceutical Group Major Business
Table 112. CSPC Pharmaceutical Group Meropenem for Injection Product and Services
Table 113. CSPC Pharmaceutical Group Meropenem for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. CSPC Pharmaceutical Group Recent Developments/Updates
Table 115. CSPC Pharmaceutical Group Competitive Strengths & Weaknesses
Table 116. Shenzhen Haibin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 117. Shenzhen Haibin Pharmaceutical Major Business
Table 118. Shenzhen Haibin Pharmaceutical Meropenem for Injection Product and Services
Table 119. Shenzhen Haibin Pharmaceutical Meropenem for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. Shenzhen Haibin Pharmaceutical Recent Developments/Updates
Table 121. Shenzhen Haibin Pharmaceutical Competitive Strengths & Weaknesses
Table 122. Global Key Players of Meropenem for Injection Upstream (Raw Materials)
Table 123. Global Meropenem for Injection Typical Customers
Table 124. Meropenem for Injection Typical Distributors
LIST OF FIGURES
Figure 1. Meropenem for Injection Picture
Figure 2. World Meropenem for Injection Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Meropenem for Injection Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Meropenem for Injection Production (2021-2032) & (K Units)
Figure 5. World Meropenem for Injection Average Price (2021-2032) & (US$/Unit)
Figure 6. World Meropenem for Injection Production Value Market Share by Region (2021-2032)
Figure 7. World Meropenem for Injection Production Market Share by Region (2021-2032)
Figure 8. North America Meropenem for Injection Production (2021-2032) & (K Units)
Figure 9. Europe Meropenem for Injection Production (2021-2032) & (K Units)
Figure 10. China Meropenem for Injection Production (2021-2032) & (K Units)
Figure 11. Japan Meropenem for Injection Production (2021-2032) & (K Units)
Figure 12. India Meropenem for Injection Production (2021-2032) & (K Units)
Figure 13. Meropenem for Injection Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Meropenem for Injection Consumption (2021-2032) & (K Units)
Figure 16. World Meropenem for Injection Consumption Market Share by Region (2021-2032)
Figure 17. United States Meropenem for Injection Consumption (2021-2032) & (K Units)
Figure 18. China Meropenem for Injection Consumption (2021-2032) & (K Units)
Figure 19. Europe Meropenem for Injection Consumption (2021-2032) & (K Units)
Figure 20. Japan Meropenem for Injection Consumption (2021-2032) & (K Units)
Figure 21. South Korea Meropenem for Injection Consumption (2021-2032) & (K Units)
Figure 22. ASEAN Meropenem for Injection Consumption (2021-2032) & (K Units)
Figure 23. India Meropenem for Injection Consumption (2021-2032) & (K Units)
Figure 24. Producer Shipments of Meropenem for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Meropenem for Injection Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Meropenem for Injection Markets in 2025
Figure 27. United States VS China: Meropenem for Injection Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Meropenem for Injection Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Meropenem for Injection Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Meropenem for Injection Production Market Share 2025
Figure 31. China Based Manufacturers Meropenem for Injection Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Meropenem for Injection Production Market Share 2025
Figure 33. World Meropenem for Injection Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Meropenem for Injection Production Value Market Share by Type in 2025
Figure 35. 0.25 g (Calculated as C??H??N?O?S)
Figure 36. 0.5 g (Calculated as C??H??N?O?S)
Figure 37. 1.0 g (Calculated as C??H??N?O?S)
Figure 38. World Meropenem for Injection Production Market Share by Type (2021-2032)
Figure 39. World Meropenem for Injection Production Value Market Share by Type (2021-2032)
Figure 40. World Meropenem for Injection Average Price by Type (2021-2032) & (US$/Unit)
Figure 41. World Meropenem for Injection Production Value by Clinical Indication, (USD Million), 2021 & 2025 & 2032
Figure 42. World Meropenem for Injection Production Value Market Share by Clinical Indication in 2025
Figure 43. Severe Hospital-acquired Infections
Figure 44. Drug-resistant Gram-negative Infections
Figure 45. Others
Figure 46. World Meropenem for Injection Production Market Share by Clinical Indication (2021-2032)
Figure 47. World Meropenem for Injection Production Value Market Share by Clinical Indication (2021-2032)
Figure 48. World Meropenem for Injection Average Price by Clinical Indication (2021-2032) & (US$/Unit)
Figure 49. World Meropenem for Injection Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 50. World Meropenem for Injection Production Value Market Share by Application in 2025
Figure 51. Hospital
Figure 52. Clinic
Figure 53. Others
Figure 54. World Meropenem for Injection Production Market Share by Application (2021-2032)
Figure 55. World Meropenem for Injection Production Value Market Share by Application (2021-2032)
Figure 56. World Meropenem for Injection Average Price by Application (2021-2032) & (US$/Unit)
Figure 57. Meropenem for Injection Industry Chain
Figure 58. Meropenem for Injection Procurement Model
Figure 59. Meropenem for Injection Sales Model
Figure 60. Meropenem for Injection Sales Channels, Direct Sales, and Distribution
Figure 61. Methodology
Figure 62. Research Process and Data Source
Figure 1. Meropenem for Injection Picture
Figure 2. World Meropenem for Injection Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Meropenem for Injection Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Meropenem for Injection Production (2021-2032) & (K Units)
Figure 5. World Meropenem for Injection Average Price (2021-2032) & (US$/Unit)
Figure 6. World Meropenem for Injection Production Value Market Share by Region (2021-2032)
Figure 7. World Meropenem for Injection Production Market Share by Region (2021-2032)
Figure 8. North America Meropenem for Injection Production (2021-2032) & (K Units)
Figure 9. Europe Meropenem for Injection Production (2021-2032) & (K Units)
Figure 10. China Meropenem for Injection Production (2021-2032) & (K Units)
Figure 11. Japan Meropenem for Injection Production (2021-2032) & (K Units)
Figure 12. India Meropenem for Injection Production (2021-2032) & (K Units)
Figure 13. Meropenem for Injection Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Meropenem for Injection Consumption (2021-2032) & (K Units)
Figure 16. World Meropenem for Injection Consumption Market Share by Region (2021-2032)
Figure 17. United States Meropenem for Injection Consumption (2021-2032) & (K Units)
Figure 18. China Meropenem for Injection Consumption (2021-2032) & (K Units)
Figure 19. Europe Meropenem for Injection Consumption (2021-2032) & (K Units)
Figure 20. Japan Meropenem for Injection Consumption (2021-2032) & (K Units)
Figure 21. South Korea Meropenem for Injection Consumption (2021-2032) & (K Units)
Figure 22. ASEAN Meropenem for Injection Consumption (2021-2032) & (K Units)
Figure 23. India Meropenem for Injection Consumption (2021-2032) & (K Units)
Figure 24. Producer Shipments of Meropenem for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Meropenem for Injection Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Meropenem for Injection Markets in 2025
Figure 27. United States VS China: Meropenem for Injection Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Meropenem for Injection Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Meropenem for Injection Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Meropenem for Injection Production Market Share 2025
Figure 31. China Based Manufacturers Meropenem for Injection Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Meropenem for Injection Production Market Share 2025
Figure 33. World Meropenem for Injection Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Meropenem for Injection Production Value Market Share by Type in 2025
Figure 35. 0.25 g (Calculated as C??H??N?O?S)
Figure 36. 0.5 g (Calculated as C??H??N?O?S)
Figure 37. 1.0 g (Calculated as C??H??N?O?S)
Figure 38. World Meropenem for Injection Production Market Share by Type (2021-2032)
Figure 39. World Meropenem for Injection Production Value Market Share by Type (2021-2032)
Figure 40. World Meropenem for Injection Average Price by Type (2021-2032) & (US$/Unit)
Figure 41. World Meropenem for Injection Production Value by Clinical Indication, (USD Million), 2021 & 2025 & 2032
Figure 42. World Meropenem for Injection Production Value Market Share by Clinical Indication in 2025
Figure 43. Severe Hospital-acquired Infections
Figure 44. Drug-resistant Gram-negative Infections
Figure 45. Others
Figure 46. World Meropenem for Injection Production Market Share by Clinical Indication (2021-2032)
Figure 47. World Meropenem for Injection Production Value Market Share by Clinical Indication (2021-2032)
Figure 48. World Meropenem for Injection Average Price by Clinical Indication (2021-2032) & (US$/Unit)
Figure 49. World Meropenem for Injection Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 50. World Meropenem for Injection Production Value Market Share by Application in 2025
Figure 51. Hospital
Figure 52. Clinic
Figure 53. Others
Figure 54. World Meropenem for Injection Production Market Share by Application (2021-2032)
Figure 55. World Meropenem for Injection Production Value Market Share by Application (2021-2032)
Figure 56. World Meropenem for Injection Average Price by Application (2021-2032) & (US$/Unit)
Figure 57. Meropenem for Injection Industry Chain
Figure 58. Meropenem for Injection Procurement Model
Figure 59. Meropenem for Injection Sales Model
Figure 60. Meropenem for Injection Sales Channels, Direct Sales, and Distribution
Figure 61. Methodology
Figure 62. Research Process and Data Source
